Physician profile
Bradley Trinidad
NPI 1578918520
$71,462.76
in general payments reported to CMS, 2019-2025
44 companies · $29K in 2025
The $29K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $873 · 2021: $2,036 · 2022: $3,563 · 2023: $4,769 · 2024: $31K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $12K · Travel and Lodging: $7,004 · Honoraria: $5,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,000.00 |
| Food and Beverage | $11,999.58 |
| Travel and Lodging | $7,003.89 |
| Honoraria | $5,160.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cagent Vascular INC | $27,657.77 | 2023-2025 | Serrantor |
| Penumbra, INC. | $23,772.98 | 2022-2025 | Indigo System, Penumbra Coil 400, Benchmark |
| Bard Peripheral Vascular, INC. | $4,700.46 | 2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Lifestent Solo Vascular Stent |
| Bolton Medical INC | $2,537.61 | 2021-2025 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $2,417.68 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Inari Medical, INC. | $1,988.06 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Asahi Intecc USA, INC. | $1,458.69 | 2023-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Endologix LLC | $1,032.23 | 2019-2025 | Alto Abdominal Stent Graft System |
| Angiodynamics, INC. | $713.67 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Imperative Care, INC | $417.76 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Stryker Corporation | $410.42 | 2025 | Clottriever Bold Catheter, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $399.02 | 2025 | Rotarexs 6 F X 135 Cm, Crosser Iq, Lutonix Drug Coated Balloon |
| Medtronic Vascular, INC. | $383.26 | 2019-2020 | |
| Cook Medical LLC | $363.43 | 2019-2025 | Rosen |
| Abbott Laboratories | $354.99 | 2022-2025 | Coroflow, Diamondback Peripheral, Eterna |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $340.19 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $222.95 | 2021-2025 | General - Vascular Intervention, Eluvia, Ranger |
| Baxter Healthcare | $209.70 | 2021-2022 | |
| Medtronic, INC. | $208.34 | 2022-2025 | Endurant Iis, Abre, Hawkone |
| Shockwave Medical, INC | $187.66 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanara Medtech INC. | $152.79 | 2022 | |
| Cvrx, INC. | $149.29 | 2022-2025 | Barostim Neo System |
| Smith+Nephew, INC. | $149.14 | 2023-2024 | Stravix, Oasis, Grafix |
| Avinger INC. | $142.00 | 2023 | Pantheris |
| Ethicon US, LLC | $134.71 | 2025 | Dermabond Prineo, Vistaseal, Surgicel Nu-Knit |
| Intact Vascular, INC. | $117.00 | 2019 | |
| Solventum Corporation | $108.15 | 2024-2025 | Activ.A.C., Prevena, V.A.C.Ulta |
| Getinge USA Sales, LLC | $106.11 | 2020 | |
| Kerecis Limited | $85.77 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $70.55 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Surmodics, INC. | $64.24 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Philips North America LLC | $58.15 | 2025 | IV Other |
| Janssen Pharmaceuticals, INC | $56.31 | 2022-2023 | Xarelto |
| Artivion, INC. | $47.53 | 2022-2023 | Photofix Decellularized Bovine Pericardium, Vascular, Jotec Products |
| Quest Medical INC. | $42.50 | 2021 | |
| Reflow Medical INC | $41.75 | 2025 | |
| Melinta Therapeutics, LLC | $31.31 | 2024 | Rezzayo, Kimyrsa |
| Lemaitre Vascular, INC. | $23.22 | 2025 | Hydro Lemaitre Valvulotome |
| Abbvie INC. | $22.31 | 2023 | Avycaz |
| Convatec INC. | $20.38 | 2022 | |
| Veryan Medical Incorporated | $19.52 | 2025 | Biomimics 3d Vascular Stent System |
| Baylis Medical Technologies INC. | $16.29 | 2025 | |
| Tactile Systems Technology INC | $13.72 | 2025 | Flexitouch Plus, Nimbl |
| Contego Medical, INC | $13.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Trinidad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.